Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jan 9, 2018
Finance

Stars in China

Biotech winners, losers in 4Q17
BioCentury | Jul 25, 2016
Regulation

Salvage in psoriasis?

Why brodalumab fills a small but important niche in psoriasis
BioCentury | Mar 14, 2016
Company News

Boehringer Ingelheim, AbbVie deal

BioCentury | Mar 14, 2016
Product Development

The missing piece

How AbbVie's Boehringer deal advances its Humira replacement strategy
Items per page:
1 - 10 of 12